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1. Introduction 
Obstruction of the bile ducts in man is almost 
invariably accompanied by the appearance of an 
abnormal plasma lipoprotein in the LDL* class 
called lipoprotein X [ 1,2]. This lipoprotein has a 
unique lipid composition characterized by a high con- 
tent of phospholipids and a cholesterol ester/cholesterol 
ratio considerably below 1.0. Furthermore, the 
protein content is low and the protein part consists 
mainly of C-proteins and albumin, whereas no 
B-protein is found [ 1,3]. The occurrence of an 
analogous component with a lipid composition simi- 
lar to that of human LP-X has recently been observed 
in dog’s plasma after experimentally induced biliary 
obstruction [4,5]. 
As part of a current study of the abnormal lipo- 
protein metabolism in liver-biliary disease, we have 
studied the plasma lipoprotein distribution in dogs 
by zonal ultracentrifugation after induction of 
obstructive jaundice. The present report describes the 
occurrence of an abnormal cholestatic LDL compo- 
nent with a cholesterol ester/cholesterol ratio that 
does not differ from that of normal canine LDL. 
2. Materials and methods 
2.1. Animal experiments 
Eight mongrel dogs weighing 16 to 22 kg were 
*Abbreviations: VLDL, very low density lipoprotein; LP-X, 
lipoprotein X; LDL, low density lipoprotein; B-protein, 
major apoprotein of human LDL; C-proteins, the major 
apoproteins of human VLDL; SDS, sodium dodecylsulphate. 
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fed on commercial dog food during the whole experi- 
mental period. The common bile duct was sectioned 
in six dogs under anaesthesia with sodium thiome- 
bumal (20-30 mg/kg intravenously). Two other 
dogs were sham-operated. All blood samples were 
drawn after 12 h fasting with EDTA as anticoagulant. 
2.2. Zonal ultracentrifugation 
Zonal ultracentrifugation was performed with a 
Ti-14 zonal rotor in a Beckman L2-65B ultracentrifuge. 
A 600 ml NaBr gradient (1 .OO- 1.15 g/cm3, linear to 
rotor volume) containing 0.01 M Tris-HCl and 0.001 
M EDTA pH 7.4 was employed for the separation of 
VLDL-LDL. The density of the plasma samples was 
adjusted to 1.16 g/cm3 with solid NaBr before intro- 
duction to the rotor. Centrifugation was carried out 
at t15’C for 3 h at 48 000 rev/min (max 172 000 g). 
In some experiments a modified gradient (1.08-l. 19 
g/cm3) and a shorter running time (1.5 h) was used. 
The rotor was center-unloaded and the u.v.-absorbance 
at 280 nm was continuously monitored. 
2.3. Chromatography on hydroxyapatite 
Chromatography on hydroxyapatite was performed 
with a commercial product obtained from Bio Rad, 
Calif. (Bio Gel HPT). The absorbance at 280 nm of 
the effluent was continuously monitored. 
2.4. Analytical methods 
Electroimmunoassay was performed as described 
by Laurel1 [6], with the use of an antiserum to human 
&lipoprotein showing a distinct cross-reaction against 
dog LDL. Agar gel electrophoresis was performed as 
described by Seidel [7]. SDS-polyacrylamide gel 
electrophoresis was performed in a discontinuous 
system [8]. 
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Unesterified cholesterol and cholesterol esters were 
determined according to the method of Abel1 [9] 
after separation by thin layer chromatography. 
Triglycerides were determined as described by Belfrage 
et al. [lo] and phospholipids according to the method 
of Laurel1 and Tibbling [ 111. 
3. Results and discussion 
All animals, except the two sham-operated ones, 
showed unequivocal signs of obstructive jaundice 
after this period judged from the increase of plasma 
bilirubin and alkaline phosphatases and from histo- 
logical examination of liver tissue. The zonal ultra- 
centrifugal patterns of VLDL-LDL in the dogs’ 
plasma before and 7 days after the operation are 
shown in fig.1. In the normal dogs LDL class was 
partially resolved into two subclasses, tentatively 
designated LDLr and LDLa. Both of these reacted 
distinctly with antiserum to normal human LDL 
(anti-&lipoprotein). 
The plasma from all animals with bile obstruction 
showed a remarkable increase in LDL which also 
contained an additional LDLr fraction without 
immunoreactivity against anti-@lipoprotein. This 
component (provisionally called cholestatic lipo- 
protein, CLP) was obtained partially resolved 
from LDLr at a density around 1.060 g/cm3, a locali- 
zation similar to that of human LP-X [ 121, shown for 
comparison in fig. 1. This pattern remained essentially 
unchanged from 7 to 14 days after the operation. 
The ultracentrifugal patterns from the sham- 
operated animals did not differ from the preoperative 
patterns during this period. Like human LP-X, the 
CLP fraction migrated towards the cathode in agar 
gel electrophoresis. 
In order to study the part of LDL not containing 
B-protein (CLP), 75 ml of plasma were separated by 
zonal ultracentrifugation in the modified gradient 
(see Materials and methods), which gave a somewhat 
better resolution in the LDLr region. 
The CLP fraction was further fractionated by 
hydroxyapatite chromatography. As seen in fig.2 
most of the lipoprotein material was eluted with low 
concentrations of phosphate buffer (peaks I and II). 
This material migrated cathodically in agar gel electro- 
phoresis [7]. The small amounts of material appearing 
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Fig.1. Zonal ultracentrifugal LDL patterns obtained with 
(a) 28 ml normal canine plasma; (b) 28 ml canine plasma 7 
days after ligation of the common bile duct; (c) 15 ml 
human cholestatic plasma. Run time 3 h at 48 000 revlmin. 
(-) A,,,; (-) the density gradient after centrifugation 
determined at 20°C; (A) the distribution of material reacting 
with anti-human-/?-lipoprotein in electroimmuno assay. Frac- 
tions were pooled as indicated by the bars. 
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Fig.2. Hydroxyapatite chromatography of the CLP fraction 
obtained by zonal ultracentrifugation (&J(b)). Column 
dimensions: 2.6 X 30 cm. Elution with a linear gradient 
ranging from 0.05 M to 0.6 M sodium phosphate buffer, 
pH 7.0 (-) A,,,; (A) distribution of immunoreactivity 
against anti-human p-lipoprotein; (-) phosphate concen- 
tration. The lower part of the figure shows the results of 
agar electrophoresis according to Seidel et al. [ 71. 
late in the diagram (peak IV) showed a distinct pre- 
cipiting reaction with human anti-/3-lipoprotein, and 
eluted in the same place as the main part of normal 
canine and human LDL. The small peak III has not 
as yet been characterized with regard to its protein and 
lipid composition. The lipid composition of separated 
fractions is presented in table 1. CLP is characterized 
by its high content of phospholipids and low content 
of triglycerides, and this was also characteristic for 
the cholestatic LDLr in contrast to normal canine 
LDLr, indicating the presence of abnormal components 
also in this fraction. Surprisingly enough CLP had a 
cholesterol ester/cholesterol ratio of about 4, a value 
even exceeding that of the normal LDLr. This ratio is 
quite different from that found for human LP-X and 
the finding also contrasts with previous results on the 
canine LP-X analogue [4,5]. When cholestatic canine 
plasma was subjected to the fractionation procedure 
used for the preparation of LP-X by other authors 
[3,5], the lipid composition of the isolated material 
did not differ from that given for the abnormal com- 
ponent isolated by zonal ultracentrifugation and 
hydroxy apatite chromatography (table 1). The lipo- 
protein material migrating cathodically in agar gel 
electrophoresis [7] was also recovered, and again the 
lipid composition was the same as previously found 
for CLP. 
The presence of an apoprotein analogous to human 
B-protein in canine LDLr and LDLz before and after 
induction of cholestasis was established by the distinct 
immunoprecipitates obtained on electroimmuno 
assay against an antiserum to human B-protein (anti- 
&lipoprotein). No distinct immuno-precipitates were 
observed when CLP was tested in the same way. 
The SDS-gel electrophoretic patterns (fig.3) of 
normal canine LDLr and LDLl were very similar to 
each other and contained one distinct component 
with a mol. wt. around 28 000 and several faint bands 
Table 1 
Lipid and protein composition (wt %) of normal canine LDL, and of lipoproteins 
isolated after 14 days of obstruction 
Normal LDL, 
Cholestatic LDL, 
Abnormal lipoprotein 
(CLP) after zonal 
ultracentrifugation 
Abnormal lipoprotein 
after hydroxyapatite 
chromatography 
fraction I 
fraction II 
Protein Triglyc- Unesterified 
erides cholesterol 
24.5 18.0 6.5 
13.5 7.0 9.0 
9.0 2.0 10.0 
9.0 <2 9.0 
9.0 <2 8.5 
Cholesterol Phospho- 
esters lipids 
21.5 29.5 
30.5 40.0 
39.5 39.5 
35.5 44.5 
36.5 44.0 
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Fig.3. SDS-gel electrophoresis of LDL-fractions isolated by 
zonal ultracentrifugation. All samples contained 30 I.rg of 
protein. (a) mixture of human VLDL and human plasma 
albumin; (b) human LDL; (c) normal canine LDL; (d) normal 
canine LDL,; (e) cholestatic canine LDL,; (f) cholestatic 
canine LDL,; (g) abnormal ipoprotein (CLP); (h) human 
LP-X. 
with mol. wts ranging between 7 000 and 70 000, 
which is in contrast with the composition of human 
LDL but consistent with earlier observations in dogs 
[ 131. The 28 000 dalton apoprotein of canine LDL 
apparently corresponds to the human apoA-I as judged 
from molecular size and from its immunological cross 
reaction in gel immunodiffusion with a specific anti- 
serum against human apoA-I. The LDLr and LDLz 
from cholestatic dogs were still very similar to each 
other, but showed a relative increase of several com- 
ponents also present in small amounts in normal canine 
LDL:This increase was even more noticeable in CLP, 
especially in the 40 000 dalton region. Hydroxyapatite 
chromatography of CLP obtained by zonal ultracen- 
trifugation did not change the apoprotein pattern seen 
in fig.3g. 
In conclusion, the isolated abnormal canine lipo- 
protein fraction resembles the human lipoprotein X 
in the following respects: both are lipoproteins in 
the LDL class occurring in cholestasis with cathodic 
migration in agar gel electrophoresis, with high con- 
tents of phospholipids, and with low contents of 
triglycerides, and apparent lack of B-protein. The 
canine CLP, however, differs strikingly from human 
LP-X considering the cholesterol ester/cholesterol 
ratio and apoprotein composition. Although the choles- 
tatic canine lipoprotein bears much in common with 
human LP-X, the dissimilarities observed by us, imply 
that obstructive jaundice does not affect the metabo- 
lism of cholesterol in dog in the same way as in man. 
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